Americans spend more on the top 20 most prescribed drugs than the rest of the world combined, a . According to report good From advocacy groups Public Citizen, politicians struggle to rein in costs while underscoring the nation’s rising health expenditures.
For 17 of the 20 best-selling drugs in the world in 2020, drug companies generated more revenue from US sales than they did in every other country, according to Public Citizen’s analysis of company filings.
For 11 of the top-20 drugs, US sales revenue was twice as much as sales in the rest of the world, and for some drugs the disparity was even greater.
For example, the pharma firm Gilead made $6.1 billion selling the HIV drug Biktarvi in the US, five times more than the rest of the world ($1.2 billion).
For AbbVie’s Humira, an autoimmune disease drug, sales revenue in the US ($16 billion) was four times that of the rest of the world ($4 billion), and Eli Lilly’s diabetes drug Trulicity ($3.8 billion). US sales revenue for Amgen and Pfizer’s autoimmune disease drug Enbrel ($4.9 billion) and Roche’s multiple sclerosis drug Ocrevus ($3.8 billion) for the rest of the world ($1.2 billion, $1.5 billion and $1 billion, respectively) was triple that.
$158 billion. The same is true of sales revenue from the top 20 best-selling drugs. US sales made up $101 billion of this, about two-thirds of that.
America does don’t buy Or Use More drugs than the rest of the world—research keeps consumption on par with other wealthy countries—it simply pays more for what it uses. This is in line with its spending on healthcare complete, which is far higher than similar countries and receives far less. A major factor in skyrocketing prices is the government’s inability, or refusal, to negotiate lower prices. despite being bipartisan a settlement On the need to bring down the prices of prescription drugs, efforts to achieve this have failed.
Why are the cost of prescription drugs so high in the US? (financial Times)